On August 7, 2023, Gossamer Bio, Inc. closed the transaction. The transaction included participation from 70 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.59 USD | +1.90% | -4.82% | -35.34% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
33.17 USD | +1.56% | +1.94% | 2.66B | ||
0.59 USD | +1.90% | -4.82% | 133M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.34% | 133M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- GOSS Stock
- News Gossamer Bio, Inc.
- Gossamer Bio, Inc. announced that it has received $211.849524 million in funding from a group of investors